Literature DB >> 10699929

Galectin-3 overexpression protects from apoptosis by improving cell adhesion properties.

P Matarrese1, O Fusco, N Tinari, C Natoli, F T Liu, M L Semeraro, W Malorni, S Iacobelli.   

Abstract

Galectin-3 is a carbohydrate-binding protein endowed with affinity for beta-galactosides. It plays a role in cell-cell and cell-matrix interactions. Furthermore, it has been hypothesized to be involved in tumor progression and metastasis. To address the role of galectin-3 in the invasive and metastatic processes, we stably overexpressed galectin-3 in human breast carcinoma cell lines, and we evaluated the influence of elevated galectin-3 expression on several cell features, including cellular homotypic and heterotypic interactions and cell survival. No differences in various parameters related with cell growth features and proliferation were detected. By contrast, we found that galectin-3 overexpressing cells, with respect to low galectin-3 expressing cells, exerted: (1) a significantly enhanced adhesion to laminin, fibronectin and vitronectin exerted both directly or via increased expression of specific integrins, e.g., alpha-4 and beta-7; (2) a remodeling of those cytoskeletal elements associated with cell spreading, i.e., microfilaments; (3) an enhanced survival upon exposure to different apoptotic stimuli, such as cytokine and radiation. Collectively, our results indicate that overexpression of galectin-3 may play a role in tumor cell invasion and metastasis by specifically influencing cell adhesion to the extracellular matrix. This may confer selective survival advantage and resistance to the particular homeless-induced apoptosis called anoikia. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10699929

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  71 in total

1.  Altered expression of galectin-3 induces cortical thymocyte depletion and premature exit of immature thymocytes during Trypanosoma cruzi infection.

Authors:  Elizangela Silva-Monteiro; Luciana Reis Lorenzato; Oscar Kenji Nihei; Mara Junqueira; Gabriel Adrián Rabinovich; Daniel Kaiyuan Hsu; Fu-Tong Liu; Wilson Savino; Roger Chammas; Déa Maria Serra Villa-Verde
Journal:  Am J Pathol       Date:  2007-02       Impact factor: 4.307

Review 2.  Nuclear transport of galectin-3 and its therapeutic implications.

Authors:  Tatsuyoshi Funasaka; Avraham Raz; Pratima Nangia-Makker
Journal:  Semin Cancer Biol       Date:  2014-03-19       Impact factor: 15.707

3.  The expressions and clinical significances of tissue and serum galectin-3 in pancreatic carcinoma.

Authors:  Ling Xie; Wen-Kai Ni; Xu-Dong Chen; Ming-Bing Xiao; Bu-You Chen; Song He; Cui-Hua Lu; Xiao-Yan Li; Feng Jiang; Run-Zhou Ni
Journal:  J Cancer Res Clin Oncol       Date:  2012-02-25       Impact factor: 4.553

4.  Galectin binding to Mgat5-modified N-glycans regulates fibronectin matrix remodeling in tumor cells.

Authors:  Annick Lagana; Jacky G Goetz; Pam Cheung; Avraham Raz; James W Dennis; Ivan R Nabi
Journal:  Mol Cell Biol       Date:  2006-04       Impact factor: 4.272

5.  Identification of Mac-2-binding protein as a putative marker of neuroendocrine tumors from the analysis of cell line secretomes.

Authors:  Rajaventhan Srirajaskanthan; Martyn E Caplin; Mark G Waugh; Jennifer Watkins; Tim Meyer; J Justin Hsuan; Nicholas J Beaumont
Journal:  Mol Cell Proteomics       Date:  2009-12-17       Impact factor: 5.911

6.  Galectin-3 enhances angiogenic and migratory potential of microglial cells via modulation of integrin linked kinase signaling.

Authors:  Umadevi V Wesley; Raghu Vemuganti; Emine R Ayvaci; Robert J Dempsey
Journal:  Brain Res       Date:  2012-12-14       Impact factor: 3.252

7.  Galectin-1 induces nuclear translocation of endonuclease G in caspase- and cytochrome c-independent T cell death.

Authors:  H P Hahn; M Pang; J He; J D Hernandez; R-Y Yang; L Y Li; X Wang; F-T Liu; L G Baum
Journal:  Cell Death Differ       Date:  2004-12       Impact factor: 15.828

8.  Galectin-3 is an important mediator of VEGF- and bFGF-mediated angiogenic response.

Authors:  Anna I Markowska; Fu-Tong Liu; Noorjahan Panjwani
Journal:  J Exp Med       Date:  2010-08-16       Impact factor: 14.307

9.  Effects of galectin-3 inhibition on endometrial cell cycle and adhesion.

Authors:  Caixia Lei; Wei Zhang; Xiaowei Sun; Guoping Du; Li Wang; Yinkun Liu
Journal:  Front Med China       Date:  2007-10

10.  Bisecting GlcNAc residues on laminin-332 down-regulate galectin-3-dependent keratinocyte motility.

Authors:  Yoshinobu Kariya; Chihiro Kawamura; Toshiki Tabei; Jianguo Gu
Journal:  J Biol Chem       Date:  2009-11-25       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.